Carbon Monoxide and Their Donor (CORM-2) Change the Healing Rate of Skin Wound Healing in Mice Through Reduced Expression of Aquaporin-3

Carbon monoxide, which is a toxic gas, has a beneficial effect on cells in low doses. It is known that low concentrations of this gas are produced in the body during the decay of heme-containing proteins and have pro-apoptotic, anti-inflammatory, anti-allergic, vasodilator effects, stimulating angiogenesis. The danger of using this gas is the difficulty of its dosage. CO donors are used to controlling the amount and gradual release of carbon monoxide. This study studied the effect of treatment with CO and donor CORM-2 on wound healing processes in laboratory mice. Treatment with CO and CORM-2 reduced the healing rate of skin wounds in laboratory mice. The greatest delay in healing was observed in animals whose wounds were treated with CO. In this group, aquaporin-3 mRNA expression was decreased to the smallest degree among all other animals. This most likely caused the appearance of crusts. CORM-2 treatment also led to a decrease in AQP3 mRNA expression, but no crusts were formed. This can be explained by the fact that CO is released slowly. Having a dry crust on the wound increases the healing time. But, the formation of a dry crust is useful in the healing of burns, because with a dry scab, pus cannot appear; with some degrees of burns, it prevents suppuration and creates a protective barrier. The study confirmed the hypothesis that CO and CORM-2 reduce AQP3 expression after treatment of damaged skin.

Keywords:

aquaporin, CO-releasing molecule, CORM-2 carbon monoxide, gasotransmitter,

PDF

___

Abdel‐Magied, N., & Shedid, S. M. (2019). The effect of naringenin on the role of nuclear factor (erythroid‐derived 2)‐like2 (Nrf2) and haem oxygenase 1 (HO‐1) in reducing the risk of oxidative stress‐related radiotoxicity in the spleen of rats. Environmental toxicology, 34(7), 788-795. doi: 10.1002/tox.22745
Beschasnyi, S. P., & Hasiuk, О. M. (2020). CO-Releasing Molecule (CORM-2) in the regulation of Ca2+ dependent K+ permeability of erythrocyte. Ukrainian Journal of Medicine, Biology and Sport, 5(2), 166-171. doi: 10.26693/jmbs05.02.166
Bollag, W. B., Aitkens, L., White, J., & Hyndman, K. A. (2020). Aquaporin-3 in the epidermis: more than skin deep. American Journal of Physiology-Cell Physiology, 318(6), C1144-C1153. doi: 10.1152/ajpcell.00075.2020
Bollag, W. B., Xie, D., Zheng, X., & Zhong, X. (2007). A potential role for the phospholipase D2-aquaporin-3 signaling module in early keratinocyte differentiation: production of a phosphatidylglycerol signaling lipid. Journal of Investigative Dermatology, 127(12), 2823-2831. doi: 10.1038/sj.jid.5700921
Boury-Jamot, M., Sougrat, R., Tailhardat, M., Le Varlet, B., Bonté, F., Dumas, M., & Verbavatz, J. M. (2006). Expression and function of aquaporins in human skin: Is aquaporin-3 just a glycerol transporter?. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1758(8), 1034-1042. doi: 10.1016/j.bbamem.2006.06.013
Brouard, S., Berberat, P. O., Tobiasch, E., Seldon, M. P., Bach, F. H., & Soares, M. P. (2002). Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-κB to protect endothelial cells from tumor necrosis factor-α-mediated apoptosis. Journal of Biological Chemistry, 277(20), 17950-17961. doi: 10.1074/jbc.M108317200
Chang, R. Y. K., Das, T., Manos, J., Kutter, E., Morales, S., & Chan, H. K. (2019). Bacteriophage PEV20 and ciprofloxacin combination treatment enhances removal of Pseudomonas aeruginosa biofilm isolated from cystic fibrosis and wound patients. The AAPS journal, 21(3), 1-8. doi: 10.1208/s12248-019-0315-0
Choudhary, V., Olala, L. O., Qin, H., Helwa, I., Pan, Z. Q., Tsai, Y. Y., ... & Bollag, W. B. (2015). Aquaporin-3 re-expression induces differentiation in a phospholipase D2-dependent manner in aquaporin-3-knockout mouse keratinocytes. Journal of Investigative Dermatology, 135(2), 499-507. doi: 10.1038/jid.2014.412
Galiano, R. D., Michaels, V, J., Dobryansky, M., Levine, J. P., & Gurtner, G. C. (2004). Quantitative and reproducible murine model of excisional wound healing. Wound repair and regeneration, 12(4), 485-492. doi: 10.1111/j.1067-1927.2004.12404.x
Hara-Chikuma, M., Satooka, H., Watanabe, S., Honda, T., Miyachi, Y., Watanabe, T., & Verkman, A. S. (2015). Aquaporin-3-mediated hydrogen peroxide transport is required for NF-κB signalling in keratinocytes and development of psoriasis. Nature communications, 6(1), 1-14. doi: 10.1038/ncomms8454
Hara-Chikuma, M., & Verkman, A. S. (2008). Prevention of skin tumorigenesis and impairment of epidermal cell proliferation by targeted aquaporin-3 gene disruption. Molecular and cellular biology, 28(1), 326-332. doi: 10.1128/MCB.01482-07
Hermann, A., Sitdikova, G. F., & Weiger, T. M. (Eds.). (2012). Gasotransmitters: physiology and pathophysiology (pp. 163-201). Berlin; Heidelberg: Springer.
Ikarashi, N., Aburada, T., Kon, R., & Sugiyama, K. (2019). Water control mechanism of byakkokaninjinto and its active components via aquaporins. Traditional & Kampo Medicine, 6(2), 57-61. doi: 10.1002/tkm2.1213
Ikarashi, N., Ogiue, N., Toyoda, E., Kon, R., Ishii, M., Toda, T., ... & Sugiyama, K. (2012). Gypsum fibrosum and its major component CaSO4 increase cutaneous aquaporin-3 expression levels. Journal of ethnopharmacology, 139(2), 409-413. doi: 10.1016/j.jep.2011.11.025
Johnson, T. E., Wells, R. J., Bell, A., Nielsen, V. G., & Olver, C. S. (2019). Carbon monoxide releasing molecule enhances coagulation and decreases fibrinolysis in canine plasma exposed to Crotalus viridis venom in vitro and in vivo. Basic & Clinical Pharmacology & Toxicology, 125(4), 328-336. doi: 10.1111/bcpt.13242
Jones, M., Kujundzic, M., John, S., & Bismarck, A. (2020). Crab vs. Mushroom: A review of crustacean and fungal chitin in wound treatment. Marine Drugs, 18(1), 64. doi: 10.3390/md18010064
Kapetanaki, S. M., Burton, M. J., Basran, J., Uragami, C., Moody, P. C., Mitcheson, J. S., ... & Raven, E. (2018). A mechanism for CO regulation of ion channels. Nature communications, 9(1), 1-10. doi: 10.1038/s41467-018-03291-z
Kirsner, R., Dove, C., Reyzelman, A., Vayser, D., & Jaimes, H. (2019). A prospective, randomized, controlled clinical trial on the efficacy of a single‐use negative pressure wound therapy system, compared to traditional negative pressure wound therapy in the treatment of chronic ulcers of the lower extremities. Wound Repair and Regeneration, 27(5), 519-529. doi: 10.1111/wrr.12727
Kolupaev, Y. E., Karpets, Y. V., Beschasniy, S. P., & Dmitriev, A. P. (2019). Gasotransmitters and their role in adaptive reactions of plant cells. Cytology and Genetics, 53(5), 392-406. doi: 10.3103/S0095452719050098
Lin, C. C., Hsiao, L. D., Cho, R. L., & Yang, C. M. (2019). Carbon monoxide releasing molecule-2-upregulated ROS-dependent heme oxygenase-1 axis suppresses lipopolysaccharide-induced airway inflammation. International Journal of Molecular Sciences, 20(13), 3157. doi: 10.3390/ijms20133157
Liu, Y., Wang, X., Xu, X., Qin, W., & Sun, B. (2019). Protective effects of carbon monoxide releasing molecule‑2 on pancreatic function in septic mice. Molecular Medicine Reports, 19(5), 3449-3458. doi: 10.3892/mmr.2019.10049
Ma, T., Hara, M., Sougrat, R., Verbavatz, J. M., & Verkman, A. S. (2002). Impaired stratum corneum hydration in mice lacking epidermal water channel aquaporin-3. Journal of Biological Chemistry, 277(19), 17147-17153. doi: 10.1074/jbc.M200925200
Magierowska, K., Korbut, E., Hubalewska-Mazgaj, M., Surmiak, M., Chmura, A., Bakalarz, D., ... & Magierowski, M. (2019). Oxidative gastric mucosal damage induced by ischemia/reperfusion and the mechanisms of its prevention by carbon monoxide-releasing tricarbonyldichlororuthenium (II) dimer. Free Radical Biology and Medicine, 145, 198-208. doi: 10.1016/j.freeradbiomed.2019.09.032
Magierowski, M., Magierowska, K., Hubalewska‐Mazgaj, M., Sliwowski, Z., Ginter, G., Pajdo, R., ... & Brzozowski, T. (2017). Carbon monoxide released from its pharmacological donor, tricarbonyldichlororuthenium (II) dimer, accelerates the healing of pre‐existing gastric ulcers. British journal of pharmacology, 174(20), 3654-3668. doi: 10.1111/bph.13968
Motterlini, R., & Foresti, R. (2017). Biological signaling by carbon monoxide and carbon monoxide-releasing molecules. American Journal of Physiology-Cell Physiology, 312(3), C302-C313. doi: 10.1152/ajpcell.00360.2016
Motterlini, R., Mann, B. E., Johnson, T. R., Clark, J. E., Foresti, R., & Green, C. J. (2003). Bioactivity and pharmacological actions of carbon monoxide-releasing molecules. Current pharmaceutical design, 9(30), 2525-2539. doi: 10.2174/1381612033453785
Olas, B. (2014). Carbon monoxide is not always a poison gas for human organism: Physiological and pharmacological features of CO. Chemico-biological interactions, 222, 37-43. doi: 10.1016/j.cbi.2014.08.005
Olsson, M., Broberg, A., Jernås, M., Carlsson, L., Rudemo, M., Suurküla, M., ... & Benson, M. (2006). Increased expression of aquaporin 3 in atopic eczema. Allergy, 61(9), 1132-1137. doi: 10.1111/j.1398-9995.2006.01151.x
Olszanecki, R., Gebska, A., & Korbut, R. (2007). The role of haem oxygenase‐1 in the decrease of endothelial intercellular adhesion molecule‐1 expression by curcumin. Basic & clinical pharmacology & toxicology, 101(6), 411-415. doi: 10.1111/j.1742-7843.2007.00151.x
Patel, S., Srivastava, S., Singh, M. R., & Singh, D. (2019). Mechanistic insight into diabetic wounds: Pathogenesis, molecular targets and treatment strategies to pace wound healing. Biomedicine & Pharmacotherapy, 112, 108615. doi: 10.1016/j.biopha.2019.108615
Qin, H., Zheng, X., Zhong, X., Shetty, A. K., Elias, P. M., & Bollag, W. B. (2011). Aquaporin-3 in keratinocytes and skin: Its role and interaction with phospholipase D2. Archives of Biochemistry and Biophysics, 508(2), 138-143. doi: 10.1016/j.abb.2011.01.014
Qureshi, O. S., Zeb, A., Akram, M., Kim, M. S., Kang, J. H., Kim, H. S., ... & Kim, J. K. (2016). Enhanced acute anti-inflammatory effects of CORM-2-loaded nanoparticles via sustained carbon monoxide delivery. European Journal of Pharmaceutics and Biopharmaceutics, 108, 187-195. doi: 10.1016/j.ejpb.2016.09.008
Singer, A. J., & Clark, R. A. (1999). Cutaneous wound healing. New England journal of medicine, 341(10), 738-746. doi: 10.1056/NEJM199909023411006
Verkman, A. S., Anderson, M. O., & Papadopoulos, M. C. (2014). Aquaporins: important but elusive drug targets. Nature reviews Drug discovery, 13(4), 259-277. doi: 10.1038/nrd4226
Verkman, A. S. (2008). A cautionary note on cosmetics containing ingredients that increase aquaporin‐3 expression. Experimental dermatology, 17(10), 871-872. doi: 10.1111/j.1600-0625.2008.00698.x
Wang, M., Yang, X., Pan, Z., Wang, Y., De La Cruz, L. K., Wang, B., & Tan, C. (2020). Towards “CO in a pill”: Pharmacokinetic studies of carbon monoxide prodrugs in mice. Journal of Controlled Release, 327, 174-185. doi: 10.1016/j.jconrel.2020.07.040
Wang, R. (Ed.). (2004). Signal Transduction and the Gasotransmitters: NO, CO, and H2S in Biology and Medicine. Springer Science & Business Media. Wu, L., & Wang, R. (2005). Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacological reviews, 57(4), 585-630. doi: 10.1124/pr.57.4.3